L'intérêt à découvert pour Ionis Pharmaceuticals donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Ionis Pharmaceuticals. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Ionis Pharmaceuticals (NASDAQ:IONS) Stock, Rapport sur les intérêts à découvert

Ionis Pharmaceuticals

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals Inc

Earnings

News

Guidance

General

MRC Global Announces Preliminary Q1 2025 Results; Sees Revenue Of ~$710M

Ashford Hospitality Trust Expects To Report Occupancy Of ~ 68% For The First Quarter Of 2025 With Average Daily Rate Of ~ $196 Resulting In RevPAR Of ~ $133

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 10.01% on an annualized basis producing an average annual return of 19.64%. Currently, Meta Platforms has a market capitalization of $1.27 trillion. 
Buying $100 In META: If an investor had bought $100 of META stock 10 years ago, it would be worth $604.54 today based on a price of $502.75 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744839024_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.54 by 3.7 percent. This is a 14.29 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $260.08 million which beat the analyst consensus estimate of $255.22 million by 1.91 percent. This is a 5.56 percent increase over sales of $246.39 million the same period last year.

Earnings Beats

HOMB

Home BancShares Q1 Adj $0.56 Beats $0.54 Estimate, Sales $260.08M Beat $255.22M Estimate

Liberty Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is a 91.67 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $977.46 million which beat the analyst consensus estimate of $954.73 million by 2.38 percent. This is a 8.90 percent decrease over sales of $1.07 billion the same period last year.

Earnings Misses

LBRT

Liberty Energy Q1 Adj EPS $0.04 Misses $0.05 Estimate, Sales $977.46M Beat $954.73M Estimate

Northern Oil and Gas Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) shares are rising in extended trading Wednesday after the company provided an update on first-quarter hedging results <a href="https://www.benzinga.com/pressreleases/25/04/b44852024/nog-provides-update-on-first-quarter-hedging-results-and-shareholder-returns">and shareholder returns</a>.
What Happened: Northern Oil and Gas reported estimated unrealized mark-to-market gains on derivatives of $9 million to $10 million for the first quarter. The unrealized gains were driven primarily by changes to the value of the company&#8217;s oil derivatives portfolio.
Northern Oil And Gas said realized hedge gains were an estimated $11 million to $12 million in the quarter, primarily driven by the company&#8217;s crude oil and Waha basis hedges. 
Northern Oil and Gas noted it added &#8220;substantial&#8221; hedges since its fourth quarter report, including hedges to oil, natural gas and Waha, Midland-Cushing and M2 basis hedges.
The company also provided an update on shareholder returns. Northern Oil and Gas said it paid dividends of approximately $42 million during the first quarter. In February, the company declared a dividend of 45 cents per share, up 7% compared to the prior quarterly dividend. The dividend is payable on April 30.
See Also: <a href="https://www.benzinga.com/news/earnings/25/04/44852989/kinder-morgan-q1-earnings-revenue-beat-eps-miss-forward-guidance-our-company-can-be-a-safe-haven-during-the-storm">Kinder Morgan Q1 Earnings: Revenue Beat, EPS Miss, Forward Guidance — &#8216;Our Company Can Be A Safe Haven During The Storm&#8217;</a>
Northern Oil and Gas also said it repurchased 499,100 shares during the quarter at an average price of $30.07. Year-to-date shareholder returns are currently around $57 million, the company said.
Northern Oil and Gas is scheduled to report first-quarter earnings after the market close on April 29. Analysts are looking for adjusted earnings of 11 cents per share and revenue of $556.94 million, per <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates.
NOG Price Action: <a href="http://benzinga.com/quote/nog">Northern Oil And Gas shares</a> were up 4.43% at $23.95 after-hours at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/color+space+illusion">fotokaleinar</a>/Shutterstock.

Dividends

Commodities

Buybacks

After-Hours Center

Movers

Northern Oil And Gas Stock Climbs On Q1 Hedging Results, Shareholder Return Update: What You Need To Know

Simmons First Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFNC#NASDAQ">SFNC</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.35 by 25.71 percent. This is a 18.75 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $209.58 million which beat the analyst consensus estimate of $209.08 million by 0.24 percent. This is a 7.43 percent increase over sales of $195.09 million the same period last year.

SFNC

Simmons First Ntl Q1 Adj $0.26 Misses $0.35 Estimate, Sales $209.58M Beat $209.08M Estimate

BANL

CBL International FY EPS $(0.136) Down From $0.045 YoY, Sales $592.50M Up From $435.90M YoY

Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) has outperformed the market over the past 10 years by 8.63% on an annualized basis producing an average annual return of 18.26%. Currently, Fiserv has a market capitalization of $117.93 billion. 
Buying $1000 In FI: If an investor had bought $1000 of FI stock 10 years ago, it would be worth $5,376.41 today based on a price of $210.11 for FI at the time of writing.
<h3>Fiserv's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744838116_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

QXO Reveals Its Intention To Make An Offering of $500M Of Shares Of Its Common Stock

Hertz Global Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) shares picked up momentum heading into Wednesday&#8217;s close and have continued to move higher in after-hours trading. Here&#8217;s a look at <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44840772/hertz-stock-zooms-25-pre-market-bill-ackmans-pershing-square-makes-46-5m-bet">what&#8217;s going on</a>.
What To Know: Hertz shares surged Wednesday morning after Bill Ackman's&nbsp;Pershing Square Capital Management filed an&nbsp;<a href="https://www.sec.gov/Archives/edgar/data/1336528/000117266125001497/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">amended 13F</a>&nbsp;showing that the firm purchased 12.71 million shares of the rental car company as of Dec. 31, representing a stake of approximately 4.1%.
About 15 minutes before the market close, CNBC&#8217;s Scott Wapner reported on &#8220;Closing Bell&#8221; that a person familiar with the matter said Ackman&#8217;s firm&#8217;s stake is actually significantly higher at 19.8%, making Pershing Square the second-largest shareholder.
&#8220;I&#8217;m also told that Pershing received a confidential treatment provision from the SEC, which allowed them to delay the filing beyond the normally required reporting period, which gave them the ability to accumulate substantially more shares since the end of December,&#8221; Wapner said.
Wapner noted that Pershing is optimistic about a turnaround under new management. The source also reportedly said Pershing&#8217;s bet is partially a tariff play since used cars aren&#8217;t impacted by tariffs.
Check This Out: <a href="https://www.benzinga.com/news/earnings/25/04/44852539/csx-shares-slide-after-worse-than-expected-q1-results-details">CSX Shares Slide After Worse-Than-Expected Q1 Results: Details</a>
Hertz reported financial results for the fourth quarter in February that fell shy of analyst estimates. The company said at the time that it was focused on "stabilizing the business" and implementing changes to "transform" the company.
Hertz announced this week that it will report first-quarter earnings after the market close on May 12. Analysts currently expect the company to report a loss of 96 cents per share and revenue of $2.01 billion, according to estimates from <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
HTZ Price Action: <a href="http://benzinga.com/quote/htz">Hertz Global shares</a> were up around 20% for the majority of Wednesday&#8217;s session. The stock surged just ahead of the bell, closing the day up 56.44% at $5.71. The stock was up another 16.11% after hours, trading at $6.63 at the time of publication, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/vieninsweden">vieninsweden</a>/Shutterstock.

Hertz Stock Accelerates Into The Close, Shares Continue To Move Higher After Hours: Here's Why

<h3>Gainers</h3>
<ul>
<li>Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) shares moved upwards by 13.8% to $6.5 during Wednesday's after-market session. The company's market cap stands at $1.9 billion. </li>
<li>NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) stock rose 6.7% to $1.75. The market value of their outstanding shares is at $87.4 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares rose 6.68% to $0.24. The company's market cap stands at $6.1 million. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) stock rose 6.6% to $2.9. The company's market cap stands at $8.1 million. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock rose 6.32% to $0.37. The company's market cap stands at $2.3 million. </li>
<li>Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) shares increased by 5.83% to $0.36. The company's market cap stands at $34.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock declined by 5.3% to $2.32 during Wednesday's after-market session. The company's market cap stands at $44.2 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares decreased by 5.17% to $0.65. The market value of their outstanding shares is at $11.6 million. </li>
<li>Freightos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGO#NASDAQ">CRGO</a>) stock declined by 4.53% to $1.9. The company's market cap stands at $95.0 million. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares decreased by 3.13% to $1.24. The company's market cap stands at $296.7 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock fell 3.11% to $0.18. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

CRGO

HTOO

KULR

NNBR

SGBX

SRFM

VCIG

WLGS

11 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares increased by 12.9% to $0.0 during Wednesday's after-market session. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) shares moved upwards by 7.6% to $2.83. The company's market cap stands at $70.3 million. </li>
<li>RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) stock increased by 5.13% to $2.56. The market value of their outstanding shares is at $96.7 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) shares increased by 5.02% to $0.93. The company's market cap stands at $17.8 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) stock rose 5.01% to $0.48. The market value of their outstanding shares is at $6.6 million. </li>
<li>Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) stock rose 4.99% to $0.13. The company's market cap stands at $7.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Charles &amp; Colvard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) shares decreased by 10.9% to $0.9 during Wednesday's after-market session. The company's market cap stands at $2.7 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) stock decreased by 10.44% to $0.65. The company's market cap stands at $9.4 million. </li>
<li>Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) stock decreased by 7.26% to $2.43. The market value of their outstanding shares is at $3.6 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) shares declined by 5.09% to $0.91. The company's market cap stands at $8.9 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) stock fell 4.47% to $0.45. The market value of their outstanding shares is at $5.1 million. </li>
<li>Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) stock decreased by 3.78% to $1.26. The market value of their outstanding shares is at $4.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTHR

NAAS

RMBL

SPHL

TOPW

VEEE

WKHS

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock moved upwards by 18.9% to $0.69 during Wednesday's after-market session. The company's market cap stands at $16.4 million. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock increased by 13.99% to $1.14. The company's market cap stands at $15.6 million. </li>
<li>Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) stock rose 10.36% to $0.46. The company's market cap stands at $105.0 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock increased by 9.44% to $0.14. The market value of their outstanding shares is at $1.6 million. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) shares rose 9.38% to $0.41. The company's market cap stands at $21.3 million. </li>
<li>Revelation Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) stock increased by 8.33% to $3.25. The company's market cap stands at $2.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aspira Womens Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWH#NASDAQ">AWH</a>) shares decreased by 49.0% to $0.04 during Wednesday's after-market session. The market value of their outstanding shares is at $1.4 million. </li>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares decreased by 23.0% to $0.19. The company's, Q4 earnings came out 3 days ago. </li>
<li>Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) stock declined by 16.99% to $32.5. The market value of their outstanding shares is at $3.8 billion. </li>
<li>Kiora Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPRX#NASDAQ">KPRX</a>) stock fell 11.35% to $2.5. The company's market cap stands at $7.5 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) shares decreased by 10.53% to $1.87. The company's market cap stands at $2.3 million. As per the press release, FY earnings came out 4 days ago. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) stock decreased by 9.44% to $0.64. The market value of their outstanding shares is at $21.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CYTK

JUNS

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

LCTX

RDHL

REVB

SXTC

SYRA

TNFA

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) stock rose 79.2% to $0.39 during Wednesday's after-market session. The market value of their outstanding shares is at $11.3 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares increased by 45.89% to $2.13. The company's market cap stands at $2.4 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) shares increased by 8.9% to $0.69. The company's market cap stands at $5.8 million. </li>
<li>Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares rose 5.06% to $0.94. The market value of their outstanding shares is at $16.6 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares increased by 4.86% to $0.68. The market value of their outstanding shares is at $12.3 million. </li>
<li>Indie Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) stock rose 4.83% to $1.95. The market value of their outstanding shares is at $358.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares declined by 10.6% to $1.61 during Wednesday's after-market session. The company's market cap stands at $41.6 million. </li>
<li>Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) stock decreased by 5.92% to $0.36. The market value of their outstanding shares is at $10.0 million. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares fell 5.28% to $0.13. The company's market cap stands at $9.3 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock decreased by 5.07% to $0.48. The company's, Q4 earnings came out 2 days ago. </li>
<li>Fatpipe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATN#NASDAQ">FATN</a>) stock fell 4.54% to $8.64. The market value of their outstanding shares is at $118.5 million. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares fell 4.0% to $7.7. The company's market cap stands at $46.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASNS

CMBM

FATN

GRYP

INDI

LIDR

SMSI

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Biotech

GSK Plc Reveals That  CDC Advisory Panel Recommends PENMENVY for Inclusion in Adolescent Meningococcal Vaccination Schedule

Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>), a one-stop AI video solution provider, today announced that we have reached a strategic cooperation with Beijing Xinlantian Education Technology Co., Ltd. (hereinafter referred to as "Xinlantian"). This cooperation marks that Baijiayun, with its cutting - edge exploration in AI and large - language model technologies, will combine with Xinlantian's professional accumulation in the field of rehabilitation training for autistic children. Together, they will provide more efficient and personalized rehabilitation training programs for autistic children.
As the AI video technology service provider with the most in-depth comprehension of education, Baijiayun brings robust technical expertise in AI large model technologies. Xinlantian, through ten years of entrepreneurial experience, has accumulated specialized rehabilitation philosophies and a wealth of practical cases. The two parties will jointly develop an intelligent diagnostic assistance platform to create personalized rehabilitation plans tailored to each child's unique condition and training needs. Leveraging big data analytics and machine learning algorithms, the platform will enable real-time monitoring of training progress and outcomes. This precision-oriented approach ensures every child receives optimally customized rehabilitation programs, maximizing progress within shorter timeframes.
Additionally, Baijiayun will provide comprehensive support including SCRM management, online school platforms, intelligent diagnostics, and regulatory tools. These resources will empower Xinlantian to achieve refined management of parent leads, unified administration of teaching operations, real-time diagnosis of developmental challenges, and intelligent oversight of nationwide branches. Through these enhancements, Xinlantian will elevate service quality to deliver more holistic and professional rehabilitation services for autistic children and their families.

Baijiayun Group Forms Strategic Partnership With Xinlantian To Combine AI Video And Large Language Model Technologies With Decade-Long Expertise In Autism Rehabilitation, For Autistic Children Across China

Alcoa Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/04/b44852023/alcoa-corporation-reports-first-quarter-2025-results">from the quarter. </a>
The Details: Alcoa reported quarterly earnings of $2.15 per share, which beat the analyst consensus estimate of $1.70. Quarterly revenue came in at $3.37 billion, which missed the analyst consensus estimate of $3.53 billion and is an increase over revenue of $2.6 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/general/social-media/25/04/44817229/chinese-tiktok-influencers-expose-cheap-nike-lululemon-suppliers-to-bypass-trump-tariffs">Chinese TikTok Influencers &#8216;Expose&#8217; Cheap Nike, Lululemon Suppliers To Bypass Trump Tariffs&nbsp;</a>
<ul>
<li>Production: Alumina production decreased 1% sequentially to 2.35 million metric tons. In the aluminum segment, production decreased 1 percent sequentially to 564,000 metric tons. </li>
<li>Shipments: In the alumina segment, third-party shipments of alumina decreased 8% sequentially. In aluminum, total shipments decreased 5% sequentially. </li>
<li>Revenue: In the alumina segment, third-party revenue decreased 8%. In the aluminum segment, third-party revenue was flat.</li>
</ul>
&#8220;During the first quarter, we maintained our pace of delivering on key operational and capital allocation objectives, including forming the joint venture to support our San Ciprián operations and repositioning debt in Australia,&#8221; said Alcoa CEO William F. Oplinger. 
&#8220;A positive aluminum market led to stronger results for the first quarter, while we continued to focus on safety, stability, and operational excellence amidst economic uncertainty,&#8221; Oplinger added. 
AA Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Alcoa shares were up 0.92% after hours at $25.30 on Wednesday.  
Read More:
<ul>
<li><a href="https://www.benzinga.com/25/04/44821791/meta-platforms-used-buy-or-bury-strategy-to-monopolize-social-media-ftc-says">Meta Used &#8216;Buy Or Bury&#8217; Strategy To Monopolize Social Media, FTC Says&nbsp;</a></li>
</ul>
Photo Courtesy of Alcoa Corp.

Alcoa Shares Gain After Mixed Q1 Results: EPS Beat, Revenues Miss

Throughout the last three months, 5 analysts have evaluated Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $107.6, a high estimate of $116.00, and a low estimate of $100.00. A 5.61% drop is evident in the current average compared to the previous average price target of $114.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744837259_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Veralto among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Nathan Jones &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $102.00&#x7C;$110.00 &#x7C; 
&#x7C;Andrew Kaplowitz &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $100.00&#x7C;$116.00 &#x7C; 
&#x7C;Deane Dray &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $110.00&#x7C;$111.00 &#x7C; 
&#x7C;Nathan Jones &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $110.00&#x7C;$116.00 &#x7C; 
&#x7C;Nathan Jones &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $116.00&#x7C;$117.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Veralto. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Veralto compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Veralto's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Veralto's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VLTO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Veralto analyst ratings.</a>
<h2>Delving into Veralto's Background</h2>
Veralto Corp is a provider of essential technology solutions that safeguard many of the world's most vital resources. The company operates in two segments: Water Quality and Product Quality &amp; Innovation. Through the WQ segment, it improves the quality and reliability of water through brands including Hach, Trojan Technologies, and ChemTreat. Through the PQI segment, the company promotes consumer trust in products and helps enable product innovation through brands including Videojet, Linx, Esko, X-Rite, and Pantone.
<h3>Financial Milestones: Veralto's Journey</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Positive Revenue Trend: Examining Veralto's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.43% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Veralto's net margin is impressive, surpassing industry averages. With a net margin of 16.88%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 11.37%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Veralto's ROA stands out, surpassing industry averages. With an impressive ROA of 3.58%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Veralto's debt-to-equity ratio is below the industry average at 1.36, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

VLTO

What Analysts Are Saying About Veralto Stock

In the preceding three months, 10 analysts have released ratings for OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $30.6, a high estimate of $38.00, and a low estimate of $26.00. Experiencing a 14.09% decline, the current average is now lower than the previous average price target of $35.62. 
<img src="https://www.benzinga.com/files/images/story/2025/1744837249_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive OneStream is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Chris Quintero &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $27.00&#x7C;$34.00 &#x7C; 
&#x7C;Terry Tillman &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $27.00&#x7C;$37.00 &#x7C; 
&#x7C;Adam Hotchkiss &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $31.00&#x7C;$36.00 &#x7C; 
&#x7C;Brett Huff &#x7C;Stephens &amp; Co. &#x7C;Announces &#x7C;Overweight &#x7C; $27.00&#x7C;- &#x7C; 
&#x7C;Brett Huff &#x7C;Stephens &amp; Co. &#x7C;Announces &#x7C;Overweight &#x7C; $27.00&#x7C;- &#x7C; 
&#x7C;Chris Quintero &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $34.00&#x7C;$37.00 &#x7C; 
&#x7C;Daniel Jester &#x7C;BMO Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $34.00&#x7C;$38.00 &#x7C; 
&#x7C;John Difucci &#x7C;Guggenheim &#x7C;Maintains &#x7C;Buy &#x7C; $35.00&#x7C;$35.00 &#x7C; 
&#x7C;Scott Berg &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $38.00&#x7C;$38.00 &#x7C; 
&#x7C;Mark Murphy &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $26.00&#x7C;$30.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to OneStream. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of OneStream compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for OneStream's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into OneStream's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on OneStream analyst ratings.</a>
<h2>Delving into OneStream's Background</h2>
OneStream Inc is an AI-enabled and extensible software platform that unifies core financial functions and broader operational data and processes within a single platform. The Digital Finance Cloud of the company provides a comprehensive, dynamic, and predictive view of the entire enterprise, providing corporate leaders the control, visibility, and agility required to proactively adjust business and day-to-day execution. Company platform unifies core financial and operational data and processes within a single platform, with solutions that maintain the integrity of corporate reporting standards for Finance while providing operationally insights for business users.
<h3>OneStream's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: OneStream's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 29.13%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: OneStream's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -23.74%, the company may face hurdles in effective cost management.
Return on Equity (ROE): OneStream's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -8.78%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -4.0%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: OneStream's debt-to-equity ratio is below the industry average at 0.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where OneStream Stands With Analysts

Press Releases

Ionis reports fourth quarter and full year 2024 financial results

New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control

Ionis to present at upcoming investor conferences

WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera

Health Care

Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting

Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S.

Comments

Ionis Pharmaceuticals

Intérêt court

Ionis Pharmaceuticals (NASDAQ:IONS) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL